Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. GNK
4. NVDA
5. PLUR
6. SPCX
7. AZN
8. FNGR
9. GSAT
10. S

Go back to Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20

SciClone Reports Second Quarter 2016 Financial Results

August 9, 2016 4:05 PM EDT

FOSTER CITY, Calif., Aug. 9, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2016.

 

Revenues: In the second quarter of 2016, SciClone reported revenues of $39.0 million, compared to $37.9 million for the same period in 2015. GAAP Diluted EPS: In the second quarter of 2016, SciClone reported GAAP diluted net earnings per share of $0.12, compared to GAAP diluted net loss per share of $0.08 for the same period in 2015.... More